Events & Presentations
Board of Directors
Historic Stock Lookup
Healthzette: The New Liver Killer: Silent, Sneaky, Deadly
April 8, 2016 | News Article
Galectin Therapeutics to Present at Needham & Company’s 15th Annual Healthcare Conference
April 7, 2016 | Press Release
March 15th Business Update Conference Call – Click Here to Access the Call
March 15, 2016 | Presentation
What are galectins and why are they a good target for the treatment of NASH?
Are you conducting clinical trials with GR-MD-02? What results have you seen so far?
Why did you choose to become the CEO of Galectin Therapeutics?
Why is fatty liver disease called "the hidden epidemic?"
What is fibrosis and what role does it play in chronic diseases such as NASH?
Galectin Therapeutics, Inc.
Financial Tear Sheet
Filings & Reports
Stock price updates every 30 minutes.
2015 Year In Review
Latest Corporate Presentation
Media Fact Sheet
Corporate Fact Sheet
Sign up for our latest updates
© 2016 Galectin Therapeutics Inc. - All Rights Reserved
Disclaimer: This site may contain